PI3K in­hibitor hit with an in­creased death risk warn­ing from FDA af­ter fi­nal tri­al re­sults emerge

The FDA sent a fresh warn­ing on Thurs­day about Se­cu­ra Bio’s em­bat­tled PI3K in­hibitor Copik­tra (du­velis­ib), which may in­crease the risk of death and se­vere …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.